Dr. Partha Basu, MD PhD, is Head of the Screening Group of the International Agency for Research on Cancer (IARC). He was Head of Gynecological Oncology at Chittaranjan National Cancer Institute, India before joining IARC in 2015. Dr. Basu’s current research projects include: a) cohort study to evaluate single dose of HPV vaccine; b) RCT to evaluate a new Indian HPV vaccine; c) RCT to evaluate thermal ablation; d) evaluation of artificial intelligence for cervical cancer early detection; e) study of vaginal microbiome in HIV+ women; f) RCT to evaluate clinical breast examination; g) evaluation of automated breast ultrasound; h) evaluation of cancer screening programmes in Europe and Latin America; i) evaluation of colorectal cancer screening in Mediterranean Region. These projects are funded by National Institute of Health (USA), Gates Foundation, American Cancer Society, MRC (UK), Norwegian Research Council, Swiss Cancer Research, Lalla Salma Foundation (Morocco), Indo-American Cancer Association etc.
Abstracts this author is presenting: